Psy108 - Cost-Utility Analysis of Tocilizumab in Combination With Corticosteroids for the Treatment of Giant Cell Arteritis in Italian Patients

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2683
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Psy44 - Tocilizumab in Combination With Corticosteroids for the Treatment of Giant Cell Arteritis: A Budget Impact Analysis in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Design of the Tocilizumab in Giant Cell Arteritis Trial

International Journal of Rheumatology
RheumatologyImmunology
2013English

Psy99 - Cost-Effectiveness of Tocilizumab + Prednisolone Compared to Standard of Care With Prednisolone Alone in Patients With Giant Cell Arteritis (Gca) in Turkey

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Utility of Contrast-Enhanced Ultrasound for the Assessment of the Carotid Artery Wall in Patients With Takayasu or Giant Cell Arteritis

European Heart Journal Cardiovascular Imaging
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2013English

The Treatment of Giant Cell Arteritis in Different Clinical Settings

Frontiers in Immunology
AllergyImmunology
2019English

Endovascular Treatment of Intracerebral Giant Cell Arteritis

Frontiers in Neurology
Neurology
2020English

Role of Oral Cyclophosphamide in the Treatment of Giant Cell Arteritis

Rheumatology
RheumatologyPharmacology
2012English

THU0340 Adrenal Insufficiency During Glucocorticoid Treatment in Patients With Polymyalgia Reumatica or Giant Cell Arteritis

2017English

Treatment of Polymyalgia Rheumatica and Giant Cell Arteritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy